Literature DB >> 24358847

Management of acute and post-operative pain in chronic kidney disease.

Malvinder S Parmar1, Kamalpreet S Parmar2.   

Abstract

Chronic kidney disease is common and patients with many co-morbid conditions frequently have to undergo surgical procedures and, therefore, require effective pain management. The pharmacokinetics of various analgesic agents are not well studied in patients with chronic kidney disease and the risk of accumulation of the main drug or their metabolites, resulting in serious adverse events, is a common scenario on medical and surgical wards. It is common for these patients to be cared for by 'non-nephrologists' who often prescribe the standard dose of the commonly used analgesics, without taking into consideration the patient's kidney function. It is important to recognize the problems and complications associated with the use of standard doses of analgesics, and highlight the importance of adjusting analgesic dosage based on kidney function to avoid complications while still providing adequate pain relief.

Entities:  

Year:  2013        PMID: 24358847      PMCID: PMC3752710.1          DOI: 10.12688/f1000research.2-28.v1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  61 in total

1.  Intravenous analgesic use in dialysis patients.

Authors:  C J Diskin; S Thomas
Journal:  Nephrol Dial Transplant       Date:  1999-10       Impact factor: 5.992

2.  Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action.

Authors:  M S Angst; M Bührer; J Lötsch
Journal:  Anesthesiology       Date:  2000-05       Impact factor: 7.892

3.  Opiate toxicity in patients with renal failure.

Authors:  B R Conway; D G Fogarty; W E Nelson; C C Doherty
Journal:  BMJ       Date:  2006-02-11

4.  [Cardiorespiratory arrest following ingestion of morphine sulfate in a patient with chronic renal failure].

Authors:  K Moreau; D Morel; P Merville; B Melon; L Potaux
Journal:  Presse Med       Date:  1997 May 3-10       Impact factor: 1.228

Review 5.  Clinical pharmacokinetics of morphine.

Authors:  P A Glare; T D Walsh
Journal:  Ther Drug Monit       Date:  1991-01       Impact factor: 3.681

Review 6.  Chronic kidney disease: psychosocial impact of chronic pain.

Authors:  Sara N Davison
Journal:  Geriatrics       Date:  2007-02

Review 7.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

8.  The prevalence and management of chronic pain in end-stage renal disease.

Authors:  Sara Nicola Davison
Journal:  J Palliat Med       Date:  2007-12       Impact factor: 2.947

9.  Respiratory effects of high-dose butorphanol.

Authors:  R L Talbert; J I Peters; S C Sorrells; R S Simmons
Journal:  Acute Care       Date:  1988

10.  Pain management in patients with chronic kidney disease.

Authors:  Phuong-Chi T Pham; Edgar Toscano; Phuong-Mai T Pham; Phuong-Anh T Pham; Son V Pham; Phuong-Thu T Pham
Journal:  NDT Plus       Date:  2009-01-30
View more
  3 in total

Review 1.  Pain Management in Pediatric Chronic Kidney Disease.

Authors:  Amanda Reis; Caitlyn Luecke; Thomas Keefe Davis; Aadil Kakajiwala
Journal:  J Pediatr Pharmacol Ther       Date:  2018 May-Jun

2.  Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients.

Authors:  Morten Baltzer Houlind; Kristian Kjær Petersen; Henrik Palm; Lillian Mørch Jørgensen; Mia Aakjær; Lona Louring Christrup; Janne Petersen; Ove Andersen; Charlotte Treldal
Journal:  Pharmaceuticals (Basel)       Date:  2018-09-18

3.  Declines and pronounced regional disparities in meperidine use in the United States.

Authors:  John M Boyle; Kenneth L McCall; Stephanie D Nichols; Brian J Piper
Journal:  Pharmacol Res Perspect       Date:  2021-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.